EMBL Forum Science and Society Seminar: David Healy - Trussed in Evidence

Value of the Information & Strength of the Argument

The value of the information lies in its vivid, concrete examples—such as the Zoloft ghostwriting brochure and the manipulation of study 329—that illustrate systemic flaws in the production and dissemination of psychiatric evidence. Healy’s argumentation is logically structured and historically grounded, tracing the evolution of patent laws and branding from 19th-century Germany to modern marketing. He effectively demonstrates how the trial system, intended to regulate drugs, ironically creates incentives for splitting illnesses to expand markets. The causal chain from clinical trial outsourcing to ghostwritten articles and guideline capture is well-supported with internal evidence, such as citation rates and impact factor comparisons. However, the argument is one-sided; Healy does not acknowledge potential benefits of industry involvement or provide counterexamples, and his advocacy for data transparency, while plausible, is not fully developed.

Scientific Rigor, Source Quality, Title Accuracy

The rigor of the talk is based on primary historical documents, trial data, and corporate communications, though specific citations are not formally presented. Healy references specific trials, companies, and publications, and the underlying data are consistent with known public controversies, such as the reanalysis of study 329. The reliance on personal experience and anecdotal evidence in some segments (e.g., the hospital guideline forms) is balanced by his academic credentials and previous work. The title ‘Trussed in Evidence’ is highly appropriate, capturing the central theme of how evidence is constrained and manipulated. The talk is part of EMBL’s Science and Society forum, which provides institutional credibility. No comments are provided, so public reception cannot be assessed.

The title 'Trussed in Evidence' aptly reflects the talk's critical examination of how evidence is constrained and manipulated in psychopharmacology.

8/10

Detailed historical analysis with specific examples, but represents a single expert viewpoint and lacks systematic peer review.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to the problem: drugs for mental health and the collapse of depression subtypes.
• 05:00Discussion of schizophrenia and antipsychotics, illustrating poor response and shortened lifespan.
• 12:00Historical branding: aspirin and heroin, and the creation of 'mood stabilizer' concept.
• 24:00Outsourcing of clinical trials and medical writing; the Zoloft ghostwriting portfolio.
• 45:00Study 329 and the 2002 World Mental Health Day; the gap between published literature and raw data.

• EMBL Science and Society Forum — Seminar series where this talk was given; provides institutional context.